iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

FDC gets USFDA approval for Ofloxacin Otic Solution, 0.3%

24 Jan 2022 , 09:16 AM

FDC Limited has announced to the exchanges regarding receipt of ANDA approval for Ofloxacin Otic Solution, 0.3%.

In a regulatory filing, the company said that it has been granted ANDA approval by United States Food and Drug Administration (U.S. FDA), for Ofloxacin Otic Solution, 0.3%.

The Company is mainly engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

On Monday morning trade, FDC stock was trading at Rs287 per piece higher by 0.65% on Sensex.

Related Tags

  • ANDA approval
  • drug
  • FDC Ltd
  • FDC Ltd FDC Ltd stocks
  • FDC Ltd shares
  • news
  • Pharma
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.